ISPE South Asia Pharmaceutical Manufacturing Conference

The Quality Advantage: From Submissions to Approval to Sustainable Global Supply

The ISPE South Asia Pharmaceutical Manufacturing Conference will focus on the product lifecycle approach from drug development to post-market approvals.  Topics will include critical approaches for successful manufacturing and leveraging quality as a competitive advantage. Speakers will include pharmaceutical and biopharmaceutical industry professionals along with regulators from FDA, MHRA, and APAC regions who are subject matter experts in quality and compliance. 

View 2019 ISPE South Asia Conference Agenda for a comprehensive list of topics, sessions, and speakers.

View Agenda


    NEW! Executive Forum For Executive Level Leaders in Pharmaceutical and Bio Manufacturing

    Assuring Due Diligence in Acquiring New Facilities 

    25 October 2019 | 1300 - 1630

    Successful integration of newly acquired manufacturing sites presents unique challenges and requires a multi-functional approach. From due diligence activity through the integration of various commercial and operational functions, formal governance supported by strict project management and the coordination of various subject matter experts from many different departments is required. By using a comprehensive approach, firms can successfully complete the integration of newly acquired facilities in a manner that optimizes the value of the investment and avoids any unintended complications.  Hear from and enjoy in-depth discussions with pharmaceutical industry leaders on transitioning a new acquisition into a unified quality culture.  Additional registration required.

    Register


    Conference Highlights


    Who Should Attend the Conference

    • Regulatory Affairs experts
    • GMP Inspectors
    • CMC professionals
    • Manufacturing and Operations professionals
    • Quality Assurance professionals
    • Quality Control professionals
    • Pharma Senior Level Managers 
    • Executive Level Leaders in Pharmaceutical and Bio Manufacturing

    Conference Learning Objectives

    • Become current on industry trends in quality & quality risk management
    • Understand quality and regulatory requirements and expectations
    • Address the recent developments and innovations in manufacturing
    • Understand the necessary elements for on-going quality sustainability

    Program Committee

    Carmelo Rosa, PsyD
    Director, Division of Drug Quality I
    FDA/CDER/OC/OMQ
    Co-Chair
    Frances M. Zipp
    President & CEO
    Lachman Consultant Services, Inc
    Co-Chair
    Joseph C. Famulare
    Vice President, Global Quality Compliance and External Relations
    Genentech, Inc.
    Russell J. Morrison, MBA, CPIP
    Senior Consultant
    Commissioning Agents, Inc. (CAI)
    Alicia Mozzachio
    Senior Advisor for International Activities
    FDA/CDER
    Caroline Rocks, CEng BE MEngSc
    Senior Process Engineer
    AbbVie, Inc.
     

    Board Ambassador

    Antonio C. Crincoli, PE
    Senior Director, Head Upjohn Global Engineering
    Pfizer Inc.